Clinical trial

Albumin Administration in Patients With Cirrhosis and Infections Unrelated to…

NCT00124228 · Hospital Clinic of Barcelona, Other · Completed

Key facts

NCT number NCT00124228
Title Albumin Administration in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis
Official title Effects of Intravenous Albumin Administration on Renal Function and Survival in Patients With Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. A Prospective, Stratified, Randomized and Controlled Study.
Acronym Infecir
Lead sponsor Hospital Clinic of Barcelona, Other
Collaborators Fondo de Investigacion Sanitaria
Status Completed
Phase Phase 3
Study type Interventional
Conditions Cirrhosis
Intervention type Drug
Interventions Human Albumin
Enrollment 110
Start date Nov 1, 2004
Primary completion Oct 1, 2008
Completion Oct 1, 2008
First posted Jul 27, 2005
Last update posted May 27, 2010
Countries Spain

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies